You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 11, November 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Platelet Monamine Oxidase in Chronic Schizophrenia

Some Enzyme Characteristics Relevant to Reduced Activity

Dennis L. Murphy, MD; Cynthia H. Donnelly; Leonard Miller, PhD; Richard J. Wyatt, MD

Arch Gen Psychiatry. 1976;33(11):1377-1381.


Abstract

• To evaluate further the basis for the reduced activity of platelet monoamine oxidase (MAO) found in chronic schizophrenic patients, a number of characteristics of the enzyme were compared between patients and controls. Equivalent and statistically significant reductions in activity of the enzyme were found in the patients when tyramine and benzylamine were used as the substrates in comparison to previously reported reductions with tryptamine as the substrate. Michaelis constants for platelet MAO from chronic schizophrenic patients with reduced enzyme activity were not different from controls. Dialysis of the enzyme from patients and controls yielded no changes in activity. Studies of other platelet enzymes, including succinate dehydrogenase, cytochrome C reductase, and lactate dehydrogenase in patients, normal controls, and a subgroup of normal controls with reduced MAO activity, showed no parallel reductions in activity in patients or controls with low MAO activity. These findings suggest that the reduced MAO activity found in chronic schizophrenic patients is apparently not accounted for by nonspecific changes in platelets or platelet mitochondria.



Author Affiliations

From the National Institute of Mental Health, Bethesda, Md.


Footnotes

Accepted for publication July 19, 1976.

Reprint requests to National Institutes of Health Clinical Center, Bldg 10, Room 3S229, Bethesda, MD 20014 (Dr Murphy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Enzyme Activity in Tourette's Syndrome
Shapiro et al.
Arch Neurol 1984;41:282-285.
ABSTRACT  

Plasma Amine Oxidase and Genetic Vulnerability to Schizophrenia
Baron et al.
Arch Gen Psychiatry 1983;40:275-279.
ABSTRACT  

Platelet Monoamine Oxidase in Affective Disorders
Edwards et al.
Arch Gen Psychiatry 1978;35:1443-1446.
ABSTRACT  

Activities of Types A and B MAO and Catechol-O-methyltransferase in Blood Cells and Skin Fibroblasts of Normal and Chronic Schizophrenic Subjects
Groshong et al.
Arch Gen Psychiatry 1978;35:1198-1205.
ABSTRACT  

Decreased Platelet Monoamine Oxidase Activity in Chronic Schizophrenia, Shown With Novel Substrates
Berrettini et al.
Arch Gen Psychiatry 1978;35:600-605.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.